62P-23691-00212
2 vaccinations
3 coded responses
22 check-ins
3 free-text entries
6 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 125 / NY
- Registered
- 2021-02-11
- Relationship
- Self
- Race
- N/A
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-11
Registered in v-safe
-
2021-02-11
Dose 1 — Moderna
-
2021-02-11
Health check-in — day 0, dose 1Feeling: Poor · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-11
Report sent to call center — day 0, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
- 2021-02-12
-
2021-02-13
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-13
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-02-14
Survey response — days 1–6 daily, dose 1MedDRA: Abdominal discomfort — Feeling: Fair · Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Upset stomachMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-14
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-02-15
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fever · Chills, Joint pains, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-15
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-02-16
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fatigue or tiredness, NauseaAdult check-in
- 2021-02-17
- 2021-02-18
- 2021-02-25
- 2021-03-04
-
2021-03-11
Dose 2 — Moderna
-
2021-03-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-14
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-17
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-20
Health check-in — day 7, dose 2Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-25
- 2021-04-01
- 2021-04-15
- 2021-04-22
-
2021-06-12
Survey response — 3 months, dose 2MedDRA: Dry skin, Feeling of body temperature change, Mastitis, Rash — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: On and off mastitis, very tired, hot and cold flashes, very dry skin, ridges in nails, rashes on skinMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-12
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2021-06-17
Call successfulDoes not wish to fill out VAERS report
- 2021-09-09
-
2022-03-12
Survey response — 12 months, dose 2MedDRA: Cough, Fatigue, Headache, Oropharyngeal pain, Rash, Respiratory tract congestion, Rhinorrhoea, Sneezing — Feeling: Poor · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Sore throat, fatigue, congestion, runny nose, headache, Cough, sneeze, rashMedDRA releases: 2024-11 · check-in free text available
-
2022-03-12
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-03-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-11 | Moderna | |
| 2 | 2021-03-11 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-02-11 | priority 2/3 | |
| 2021-02-13 | priority 2/3 | |
| 2021-02-14 | priority 2/3 | |
| 2021-02-15 | priority 2/3 | |
| 2021-06-12 | Successful 2021-06-17 |
Does not wish to fill out VAERS report |
| 2022-03-12 | Unsuccessful |
Free text
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): Upset stomach
Release 9 — 3 months, dose 2
Symptoms: On and off mastitis, very tired, hot and cold flashes, very dry skin, ridges in nails, rashes on skin
Release 11 — 12 months, dose 2
Symptoms: Sore throat, fatigue, congestion, runny nose, headache, Cough, sneeze, rash
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Dry skin | ✓ | ✓ | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Feeling of body temperature change | ✓ | ✓ | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Mastitis | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SRO | Abdominal discomfort | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release